Welcome to LookChem.com Sign In|Join Free


  • or


Post Buying Request

21568-87-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

21568-87-6 Usage


(S)-3-AMINO-HEXAHYDRO-2-AZEPINONE, also known as (S)-3-Amino-2-azepanone, is an organic compound that serves as a crucial intermediate in the synthesis of various pharmaceutical compounds. It is characterized by its hexahydro-2-azepine core structure and an amino group at the 3-position, which plays a vital role in its reactivity and potential applications.


Used in Pharmaceutical Industry:
(S)-3-AMINO-HEXAHYDRO-2-AZEPINONE is used as an intermediate in the synthesis of various pharmaceutical compounds for [application reason]. Its unique structure allows for the development of new drugs with potential therapeutic benefits.
Used in Antibacterial Applications:
In the field of antibacterial agents, (S)-3-AMINO-HEXAHYDRO-2-AZEPINONE is used as an intermediate in the synthesis of bengamide E analogs and capuramycin and its analogs. These compounds exhibit potent antibacterial properties, making them valuable in the development of new antibiotics to combat drug-resistant bacterial infections.

Check Digit Verification of cas no

The CAS Registry Mumber 21568-87-6 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,1,5,6 and 8 respectively; the second part has 2 digits, 8 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 21568-87:
116 % 10 = 6
So 21568-87-6 is a valid CAS Registry Number.



According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017


1.1 GHS Product identifier

Product name (3S)-3-aminoazepan-2-one

1.2 Other means of identification

Product number -
Other names L-Lys-lactam

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:21568-87-6 SDS

21568-87-6Relevant articles and documents

Designed proteinoid polymers and nanoparticles encapsulating risperidone for enhanced antipsychotic activity

Einat, H.,Grinberg, I.,Lugasi, L.,Margel, S.,Okun, E.,Rudnick-Glick, S.

, (2020)

Background: Nanoparticles (NPs) incorporating drug formulations can be used to facilitate passage through biological barriers including the blood–brain barrier (BBB) and increase drug delivery and bioavailability. Hence, NP-based administration may enhance the efficiency of current antipsychotics. Encapsulation within NPs can resolve aqueous solubility problems that not only reduce permeability through the BBB but also affect targeting. The present study describes a new drug delivery system based on proteinoid NPs to explore the possibility of improving drug efficacy. Risperidone (RSP) is a commonly used atypical antipsychotic medication, and was therefore selected for encapsulation by proteinoid NPs. Results: Proteinoid polymers with high molecular weight and low polydispersity were synthesized from l-amino acids and poly-l-lactic acid (PLLA) by thermal step-growth polymerization mechanism. RSP-loaded proteinoid NPs were then prepared using a self-assembly process in the presence of RSP, followed by PEGylation. The optimal PEGylated RSP-loaded NPs were characterized in terms of diameter and size distribution, drug loading, ζ-potential, cytotoxicity, biodistribution, and psychopharmacological effects. The findings indicate significantly higher antipsychotic activity of drug-loaded proteinoid NPs compared to free RSP. Conclusions: Proteinoid NPs enhance RSP delivery and may potentially increase drug efficiency by reducing dosage and side effects.[Figure not available: see fulltext.].

Chiral discrimination controlled by the solvent dielectric constant

Sakai, Kenichi,Sakurai, Rumiko,Hirayama, Noriaki

, p. 1073 - 1076 (2004)

Chiroselective molecular recognition accompanied by a change in configuration of a target substrate has been studied. (RS)-α-Amino-ε- caprolactam 1 was used as the target substrate to be resolved while N-tosyl-(S)-phenylalanine 2 was used as the chiral selector. The dielectric constant (ε) of the solvent was found to have a profound effect on the chiroselective molecular recognition. The specific chiral selector (S)-2 not only recognized both enantiomers (R)- and (S)-1 individually to be deposited as the less-soluble salt from the different solvent but also controlled the configuration and diastereomeric excess of the less-soluble diastereomeric salt by simple adjustment of the solvents dielectric constant. The chiroselective recognition mechanism was examined based on the crystal structures of the salts, (S)-1·(S)-2·H2O and (R)-1·(S)-2, obtained from the resolution process.

Design, synthesis and properties investigation of Nα-acylation lysine based derivatives

Shi, Ting-Ting,Fang, Zheng,Zeng, Wen-Bo,Yang, Zhao,He, Wei,Guo, Kai

, p. 7587 - 7593 (2019)

Amino acid-based compounds have attracted attention as environmentally friendly bio-based materials. Our group has recently developed a novel family of Nα-acylation lysine based derivatives. We introduced long chain acyl groups at the Nα position selectively by a new synthetic route that avoided the process of amino protection and deprotection. Sodium Nα-octanamide lysine (C8), sodium Nα-capramide lysine (C10) and sodium Nα-lauramide lysine (C12) can self-assemble into vesicles spontaneously. As a result, not only do they have potential in drug delivery system but also they may be used as bio-based surfactants applied in cosmetics and other industries.



Sheet 23 of 36, (2017/04/11)

Proteinoid compounds characterized by a molecular weight (Mw) of at least 15,000 Da, processes of preparing such compounds and methods of use thereof, are provided. A method of monitoring the presence and metastases of cancer in a body of an individual is further disclosed.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)


What can I do for you?
Get Best Price

Get Best Price for 21568-87-6